Oncothyreon Inc (USA) news

   Watch this stock
Showing stories 1 - 10 of about 56   

Articles published

ONTY 2.34 +0.01 (0.43%)
price chart
Biotech Stocks in Trouble- Oncothyreon Inc (USA) (NASDAQ:ONTY), Tekmira ...
Oncothyreon Inc (USA) (NASDAQ:ONTY) [Trend Analysis] plunged in last trading session following the company's tecemotide lung cancer treatment failed to show any effects in a trial in Japan.
Related articles »  
Stocks Buzz: Oncothyreon Inc (USA) (ONTY), Elbit Imaging Ltd (NASDAQ:EMITF ...
Oncothyreon Inc (USA) (NASDAQ:ONTY) announced financial results for the 2ndquarter ended June 30, 2014. Loss from operations decreased to $7.8 million for the three months ended June 30, 2014 compared with $18.0 million for the comparable period ...
Top Decliners of this Morning: Elizabeth Arden, Inc. (RDEN), Oncothyreon Inc ...  Investor Wired
Related articles »  
Oncothyreon Inc. (ONTY) EMR 63325-009 Study Misses Primary Endpoint
Merck KGaA (NYSE: MRK), Darmstadt, Germany, has informed Oncothyreon Inc. (Nasdaq: ONTY) that a randomized Phase 1/2 study, EMR 63325-009, of tecemotide compared to placebo in Japanese patients with Stage III non-small cell lung cancer did not ...
Oncothyreon cancer drug test in Japan shows 'no treatment effect,' ...  Puget Sound Business Journal (Seattle) (blog)
Oncothyreon (ONTY) Slumps, Tecemotide Fails Phase I/II Study  Zacks.com
Related articles »  
Are These Stocks Strong Investment Options? Oncothyreon Inc (USA)(NASDAQ ...
Oncothyreon Inc (USA)(NASDAQ:ONTY) suffered a 17.27% decrease in value during yesterday's trading as the stock fell forty-eight cents to finish the day at a closing price of $2.30.
Related articles »  
Mid-Day Movers ´┐ŻElizabeth Arden, Inc. (NASDAQ:RDEN),Oncothyreon Inc (USA ...
Elizabeth Arden, Inc. (NASDAQ:RDEN) announced financial results for its fourth fiscal quarter and year ended June 30, 2014.
Related articles »  
Oncothyreon Announces Acquisition of Alpine Biosciences
11, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY), a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it has acquired Alpine Biosciences, Inc., of Seattle ...
Oncothyreon, Inc. (ONTY) Tops Q2 EPS by 4c; Announces Acquisition of Alpine ...  StreetInsider.com (subscription)
Oncothyreon acquires Alpine Biosciences to enable targeted delivery of ...  News-Medical.net
Related articles »  
Earnings Reaction History: Oncothyreon Inc., 75.0% Follow-Through Indicator ...
Oncothyreon Inc. ( ONTY ) is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect light trading in the issue immediately following its quarterly earnings announcement.
Morning Alert: Oncothyreon Inc (NASDAQ:ONTY), TG Therapeutics (NASDAQ ...
VCA Inc. (NASDAQ:WOOF), a leading animal healthcare company in the United States, will present at CL King's 12th Annual Best Ideas Conference on Tuesday, September 9, 2014, at the Omni Berkshire Place Hotel in New York City.
Stocks in Focus: Oncothyreon Inc. (NASDAQ:ONTY), Seattle Genetics Inc ...
Equities research analysts at Wedbush reduced their price objective on shares of Oncothyreon Inc. (NASDAQ:ONTY) to $3.00 in a research note issued to investors on Tuesday.
Related articles »  
Worth Watching Stocks : Oncothyreon (NASDAQ:ONTY), Anika Therapeutics Inc ...
Oncothyreon Inc. (Nasdaq: ONTY) today announced that it will conduct a conference call on Monday, August 11, 2014 at 4:30 p.m.